Release Date: March 05, 2025
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Q: Can you provide more color on the market conditions and customer feedback, and how you see revenue building throughout the year? A: Yoav Zeif, CEO: Despite the current downturn in the industry, our customers remain optimistic about the long-term value of additive manufacturing. We recently held a Customer Advisory Board meeting with top industry leaders who emphasized the unique benefits of additive manufacturing, such as low volume, high mix production, and supply chain resilience. We expect revenue to build sequentially throughout the year, with gradual improvements as market conditions stabilize.
Q: What are the assumptions behind the 2025 gross margin guidance, and how do logistics or tariffs impact it? A: Eitan Zamir, CFO: Our 2024 gross margin was 49.2%, and we expect a similar level for 2025. This includes savings from last year's restructuring and product mix impacts. Tariffs have minimal impact on us due to our production locations, and they present an opportunity for onshore production, which can mitigate tariff costs for our customers.
Q: Are there any anticipated FX headwinds or divestitures affecting organic revenue growth in 2025? A: Eitan Zamir, CFO: Other than a small impact from the divestment of a Stratasys Direct business in 2024, there are no significant divestitures expected. We hedge against currency fluctuations, so FX impacts are relatively small.
Q: How do you plan to capture more market share in the denture market, and what differentiates your solution? A: Yoav Zeif, CEO: Our denture solution offers high aesthetics at a low price, transforming the business model for dentures. We are leading in this space with a significant market opportunity in Europe and the Americas. Our technology is ahead of the industry, and we have plans to penetrate the market further with both organic and inorganic strategies.
Q: Why have consumables declined for three consecutive quarters, and what is the outlook for 2025? A: Eitan Zamir, CFO: The Q4 decline in consumables was an outlier, and we expect 2025 to see higher consumables revenue than 2024. We are already seeing a return to normal levels in early 2025, and we anticipate increased utilization throughout the year.
Q: What are your thoughts on acquisition targets, and which areas interest you most? A: Yoav Zeif, CEO: We are focused on opportunities that enhance shareholder value, with a clear strategy in place. We have demonstrated strong operational capabilities and are well-positioned to capture opportunities in the market, supported by our partnership with Fortissimo Capital.
Q: How do you view the impact of AI and factory automation on your production businesses? A: Yoav Zeif, CEO: AI is essential for us, and we are investing in it through initiatives like our acquisition of Riven. AI will play a crucial role in additive manufacturing, enabling predictive maintenance and enhancing digital manufacturing processes. We see AI as a strong support for additive manufacturing.
Q: What is your outlook for 2025, and which market verticals do you have more confidence in? A: Yoav Zeif, CEO: We are cautious but confident in our guidance, considering the current market softness. We have good pipeline visibility and expect improvements in the macro environment. Key verticals include dental, aerospace and defense, and tooling, where we see significant opportunities.
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
This article first appeared on GuruFocus.Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.